|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 97, 856-863, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
RD Kempsford and DJ Hearse
Controversy surrounds the reported beneficial effects of crystalloid
cardioplegic solutions in the immature myocardium. In the present study we
have investigated the efficacy of four clinical cardioplegic solutions in
the immature myocardium to determine (1) whether cardioplegic protection
could be demonstrated and, if so, (2) the relative efficacy of the four
solutions. Isolated, working hearts (n = 6 per group) from neonatal rabbits
(aged 5 to 8 days) were perfused aerobically (37 degrees C) for 20 minutes
before a 2-minute infusion of one of four cardioplegic solutions: The St.
Thomas' Hospital No. 2, Tyers, Bretschneider, and Roe solutions. Hearts
were then rendered globally ischemic for 50 minutes at 37 degrees C before
reperfusion for 15 minutes in the Langendorff mode and 20 minutes in the
working mode. The postischemic recovery of cardiac function and leakage of
creatine kinase were compared with results in noncardioplegic control
hearts. Good protection was observed with the St. Thomas' Hospital and
Tyers solutions: The postischemic recovery of cardiac output was increased
from 21.2% +/- 12.7% in the cardioplegia-free group to 79.4% +/- 6.2% and
72.9% +/- 4.4%, respectively, in the St. Thomas' Hospital and Tyers groups
(p less than 0.01). In contrast, no protection was observed with either the
Bretschneider or Rose solutions: Cardiac output recovered to 31.7% +/-
10.3% and 5.1% +/- 3.2%, respectively, in these groups. Postischemic
creatine kinase leakage was 72.4 +/- 12.3 and 92.1 +/- 18.6 IU/15 min/gm
dry weight in the St. Thomas' Hospital and Tyers groups compared with 125.6
+/- 28.6 IU/15 min/gm dry weight in control hearts (p = no significant
difference). In the Bretschneider group, creatine kinase leakage increased
to 836.9 +/- 176.8 IU/15 min/gm dry weight (p less than 0.01 versus
noncardioplegic control hearts), and with the Roe solution the value was
269.0 +/- 93.0 IU/15 min/gm dry weight (p = no significant difference). In
conclusion, cardioplegic protection can be achieved in the immature rabbit
myocardium with both St. Thomas' Hospital and Tyers solutions, but
acalcemic solutions such as Bretschneider and Roe solutions (which may be
effective in the adult heart) increased damage in this preparation. The
reported lack of cardioplegic efficacy in the immature myocardium may
therefore reflect the choice of cardioplegic solution rather than a greater
vulnerability to injury in the neonatal heart.
ARTICLES
Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart
Cardiovascular Research, Rayne Institute, St. Thomas' Hospital, London, England.
This article has been cited by other articles:
![]() |
M. E. Jessen, A. S. Abd-Elfattah, and A. S. Wechsler Neonatal Myocardial Oxygen Consumption During Ventricular Fibrillation, Hypothermia, and Potassium Arrest Ann. Thorac. Surg., January 1, 1996; 61(1): 82 - 87. [Abstract] [Full Text] |
||||
![]() |
J. W. Hammon Jr Myocardial Protection in the Immature Heart Ann. Thorac. Surg., September 1, 1995; 60(3): 839 - 842. [Abstract] [Full Text] |
||||
![]() |
M. Aoki, F. Nomura, and J. E. Mayer Jr. Interactions between preischemic hypothermia and cardioplegic solutions in the neonatal lamb heart J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 822 - 828. [Abstract] [Full Text] |
||||
![]() |
A. Corno, R. Motterlini, L. Brenna, F. Santoro, and M. Samaja Ischaemia/reperfusion in the posthypoxaemic re-oxygenated myocardium: haemodynamic study in the isolated perfused rat heart Perfusion, January 1, 1993; 8(1): 113 - 118. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |